These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 1493851

  • 41. Effect of food on the pharmacokinetics of lonafarnib (SCH 66336) following single and multiple doses.
    Zhu Y, Statkevich P, Cutler DL.
    Int J Clin Pharmacol Ther; 2007 Oct; 45(10):539-47. PubMed ID: 17966839
    [Abstract] [Full Text] [Related]

  • 42. Priming of cultured neurons with sabeluzole results in long-lasting inhibition of neurotoxin-induced tau expression and cell death.
    Uberti D, Rizzini C, Galli P, Pizzi M, Grilli M, Lesage A, Spano P, Memo M.
    Synapse; 1997 Jun; 26(2):95-103. PubMed ID: 9131769
    [Abstract] [Full Text] [Related]

  • 43. Blood pressure reduction and pharmacokinetics of ketanserin in hypertensive patients.
    Hedner T, Pettersson A, Persson B.
    J Hypertens Suppl; 1986 Apr; 4(1):S91-3. PubMed ID: 2939221
    [Abstract] [Full Text] [Related]

  • 44. APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease.
    Aerssens J, Raeymaekers P, Lilienfeld S, Geerts H, Konings F, Parys W.
    Dement Geriatr Cogn Disord; 2001 Apr; 12(2):69-77. PubMed ID: 11173877
    [Abstract] [Full Text] [Related]

  • 45. Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients.
    Stangier J, Su CA, Roth W.
    J Int Med Res; 2000 Apr; 28(4):149-67. PubMed ID: 11014323
    [Abstract] [Full Text] [Related]

  • 46. Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol.
    Thomas JP, Tutsch KD, Cleary JF, Bailey HH, Arzoomanian R, Alberti D, Simon K, Feierabend C, Binger K, Marnocha R, Dresen A, Wilding G.
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):465-72. PubMed ID: 12451473
    [Abstract] [Full Text] [Related]

  • 47. Steady-state pharmacokinetics and safety of donepezil HCl in subjects with moderately impaired renal function.
    Nagy CF, Kumar D, Cullen EI, Bolton WK, Marbury TC, Gutierrez MJ, Hutman HW, Pratt RD.
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):18-24. PubMed ID: 15496219
    [Abstract] [Full Text] [Related]

  • 48. Pharmacokinetics of paroxetine in patients with cirrhosis.
    Dalhoff K, Almdal TP, Bjerrum K, Keiding S, Mengel H, Lund J.
    Eur J Clin Pharmacol; 1991 Nov; 41(4):351-4. PubMed ID: 1839532
    [Abstract] [Full Text] [Related]

  • 49. Effect of sabeluzole (R 58,735) on memory functions in patients with epilepsy.
    Aldenkamp AP, Overweg J, Smakman J, Beun AM, Diepman L, Edelbroek P, Gutter T, Mulder OG, vt Slot B, Vledder B.
    Neuropsychobiology; 1995 Nov; 32(1):37-44. PubMed ID: 7566521
    [Abstract] [Full Text] [Related]

  • 50. Single dose and steady state pharmacokinetics and pharmacodynamics of the ACE-inhibitor imidapril in hypertensive patients.
    Harder S, Thürmann PA, Ungethüm W.
    Br J Clin Pharmacol; 1998 Apr; 45(4):377-80. PubMed ID: 9578185
    [Abstract] [Full Text] [Related]

  • 51. Tolerability and pharmacokinetics of ebrotidine in healthy subjects given single and repeated oral doses.
    Farré M, Roset PN, Badenas JM, Ugena B, Márquez M, Albet C, Herrero E, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):528-30. PubMed ID: 9205758
    [Abstract] [Full Text] [Related]

  • 52. Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study.
    van Heeswijk RP, Veldkamp AI, Mulder JW, Meenhorst PL, Lange JM, Beijnen JH, Hoetelmans RM.
    AIDS; 2000 Jun 16; 14(9):F103-10. PubMed ID: 10894270
    [Abstract] [Full Text] [Related]

  • 53. Pharmacokinetics of ebrotidine in healthy volunteers. A summary.
    Albet C, Pérez JA, Rozman E, Márquez M, Herrero E, Ortiz JA.
    Arzneimittelforschung; 1997 Apr 16; 47(4A):535-9. PubMed ID: 9205760
    [Abstract] [Full Text] [Related]

  • 54. Comparison of the steady-state pharmacokinetics of nefazodone after administration of 200 mg twice daily or 400 mg once daily in the morning or evening.
    Marathe PH, Lee JS, Greene DS, Barbhaiya RH.
    Br J Clin Pharmacol; 1996 Jan 16; 41(1):21-7. PubMed ID: 8824689
    [Abstract] [Full Text] [Related]

  • 55. Pharmacokinetics, pharmacodynamics and safety of febuxostat, a non-purine selective inhibitor of xanthine oxidase, in a dose escalation study in healthy subjects.
    Khosravan R, Grabowski BA, Wu JT, Joseph-Ridge N, Vernillet L.
    Clin Pharmacokinet; 2006 Jan 16; 45(8):821-41. PubMed ID: 16884320
    [Abstract] [Full Text] [Related]

  • 56. Steady-state pharmacokinetics of tacrine in patients with Alzheimer's disease.
    Cutler NR, Sedman AJ, Prior P, Underwood BA, Selen A, Balogh L, Kinkel AW, Gracon SI, Gamzu ER.
    Psychopharmacol Bull; 1990 Jan 16; 26(2):231-4. PubMed ID: 2236461
    [Abstract] [Full Text] [Related]

  • 57. Pharmacokinetic interaction of sparfloxacin and digoxin.
    Johnson RD, Dorr MB, Hunt TL, Conway S, Talbot GH.
    Clin Ther; 1999 Feb 16; 21(2):368-79. PubMed ID: 10211539
    [Abstract] [Full Text] [Related]

  • 58. Pharmacokinetics of NS-105, a novel cognition enhancer. 2nd communication: distribution and transfer into fetus and milk after single administration, and effects of repeated administration on pharmacokinetics and hepatic drug-metabolizing enzyme activities in rats.
    Mukai H, Sugimoto T, Ago M, Morino A, Takaichi M, Ogawa Y, Seki H, Matsuura C, Esumi Y.
    Arzneimittelforschung; 1999 Dec 16; 49(12):977-85. PubMed ID: 10635441
    [Abstract] [Full Text] [Related]

  • 59. Single and multiple dose pharmacokinetics of ticlopidine in young and elderly subjects.
    Shah J, Teitelbaum P, Molony B, Gabuzda T, Massey I.
    Br J Clin Pharmacol; 1991 Dec 16; 32(6):761-4. PubMed ID: 1768571
    [Abstract] [Full Text] [Related]

  • 60. Multiple-dose tolerability, pharmacokinetics, and pharmacodynamics of ponesimod, an S1P1 receptor modulator: favorable impact of dose up-titration.
    Brossard P, Scherz M, Halabi A, Maatouk H, Krause A, Dingemanse J.
    J Clin Pharmacol; 2014 Feb 16; 54(2):179-88. PubMed ID: 24408162
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.